Skip to main content
PMC home page
British Journal of Cancer logoLink to British Journal of Cancer
. 1997;76(10):1367–1375. doi: 10.1038/bjc.1997.562

Relationship between vascularity, age and survival in non-small-cell lung cancer.

L M Chandrachud 1, N Pendleton 1, D M Chisholm 1, M A Horan 1, A M Schor 1
PMCID: PMC2228139  PMID: 9374385

Abstract

Lung tumours in the elderly show reduced growth potential; impaired angiogenesis may contribute to this phenomenon. Recent studies have suggested that the angiogenic potential of a tumour may be inferred by the vascularity measured in histological sections. The purpose of this study has been to determine whether vascularity is related to age, survival or other clinical parameters in resected non-small-cell lung cancer (NSCLC). A group of 88 consecutive patients with a follow-up period of at least 5 years was selected. The group exhibited a wide age range (37-78 years) and similar survival characteristics to those of the general NSCLC population. Tumour sections were stained with a pan-endothelial antibody (vWF) and vascularity was quantitated, without knowledge of the clinical details, by three methods: highest microvascular density; average microvascular density; and average microvascular volume. The results were analysed by non-parametric statistical tests. A correlation was found between all three methods of quantitation. Vascularity was not associated with age, sex, tumour type, stage, volume, size (TNM-T) nodal status (TNM-N) or survival. However, survival time was generally longer for patients with higher vascularity, reaching borderline significance (P = 0.06) for the average microvascular density values. Higher tumour volume (P = 0.02) and stage (P = 0.05) were associated with lower survival times. Using multivariate survival analysis, tumour volume was the only factor related to survival. We conclude that vascularity is not associated with age and has no significant prognostic value in NSCLC.

Full text

PDF
1373

Images in this article

1369Figure 1
on p.1369

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Axelsson K., Ljung B. M., Moore D. H., 2nd, Thor A. D., Chew K. L., Edgerton S. M., Smith H. S., Mayall B. H. Tumor angiogenesis as a prognostic assay for invasive ductal breast carcinoma. J Natl Cancer Inst. 1995 Jul 5;87(13):997–1008. doi: 10.1093/jnci/87.13.997. [DOI] [PubMed] [Google Scholar]
  2. Bossi P., Viale G., Lee A. K., Alfano R., Coggi G., Bosari S. Angiogenesis in colorectal tumors: microvessel quantitation in adenomas and carcinomas with clinicopathological correlations. Cancer Res. 1995 Nov 1;55(21):5049–5053. [PubMed] [Google Scholar]
  3. Craft P. S., Harris A. L. Clinical prognostic significance of tumour angiogenesis. Ann Oncol. 1994 Apr;5(4):305–311. doi: 10.1093/oxfordjournals.annonc.a058829. [DOI] [PubMed] [Google Scholar]
  4. Fontanini G., Bigini D., Vignati S., Basolo F., Mussi A., Lucchi M., Chine S., Angeletti C. A., Harris A. L., Bevilacqua G. Microvessel count predicts metastatic disease and survival in non-small cell lung cancer. J Pathol. 1995 Sep;177(1):57–63. doi: 10.1002/path.1711770110. [DOI] [PubMed] [Google Scholar]
  5. Giatromanolaki A., Koukourakis M., O'Byrne K., Fox S., Whitehouse R., Talbot D. C., Harris A. L., Gatter K. C. Prognostic value of angiogenesis in operable non-small cell lung cancer. J Pathol. 1996 May;179(1):80–88. doi: 10.1002/(SICI)1096-9896(199605)179:1<80::AID-PATH547>3.0.CO;2-X. [DOI] [PubMed] [Google Scholar]
  6. Hall N. R., Fish D. E., Hunt N., Goldin R. D., Guillou P. J., Monson J. R. Is the relationship between angiogenesis and metastasis in breast cancer real? Surg Oncol. 1992 Jun;1(3):223–229. doi: 10.1016/0960-7404(92)90068-v. [DOI] [PubMed] [Google Scholar]
  7. Jefferson M. F., Pendleton N., Faragher E. B., Dixon G. R., Myskow M. W., Horan M. A. 'Tumour volume' as a predictor of survival after resection of non-small-cell lung cancer (NSCLC) Br J Cancer. 1996 Aug;74(3):456–459. doi: 10.1038/bjc.1996.381. [DOI] [PMC free article] [PubMed] [Google Scholar]
  8. Kaesberg P. R., Ershler W. B. The change in tumor aggressiveness with age: lessons from experimental animals. Semin Oncol. 1989 Feb;16(1):28–33. [PubMed] [Google Scholar]
  9. Kainz C., Speiser P., Wanner C., Obermair A., Tempfer C., Sliutz G., Reinthaller A., Breitenecker G. Prognostic value of tumour microvessel density in cancer of the uterine cervix stage IB to IIB. Anticancer Res. 1995 Jul-Aug;15(4):1549–1551. [PubMed] [Google Scholar]
  10. Kreisle R. A., Stebler B. A., Ershler W. B. Effect of host age on tumor-associated angiogenesis in mice. J Natl Cancer Inst. 1990 Jan 3;82(1):44–47. doi: 10.1093/jnci/82.1.44. [DOI] [PubMed] [Google Scholar]
  11. Lauk S., Skates S., Goodman M., Suit H. D. A morphometric study of the vascularity of oral squamous cell carcinomas and its relation to outcome of radiation therapy. Eur J Cancer Clin Oncol. 1989 Oct;25(10):1431–1440. doi: 10.1016/0277-5379(89)90101-6. [DOI] [PubMed] [Google Scholar]
  12. Leon S. P., Folkerth R. D., Black P. M. Microvessel density is a prognostic indicator for patients with astroglial brain tumors. Cancer. 1996 Jan 15;77(2):362–372. doi: 10.1002/(SICI)1097-0142(19960115)77:2<362::AID-CNCR20>3.0.CO;2-Z. [DOI] [PubMed] [Google Scholar]
  13. Macchiarini P., Fontanini G., Hardin M. J., Squartini F., Angeletti C. A. Relation of neovascularisation to metastasis of non-small-cell lung cancer. Lancet. 1992 Jul 18;340(8812):145–146. doi: 10.1016/0140-6736(92)93217-b. [DOI] [PubMed] [Google Scholar]
  14. Miliaras D., Kamas A., Kalekou H. Angiogenesis in invasive breast carcinoma: is it associated with parameters of prognostic significance? Histopathology. 1995 Feb;26(2):165–169. doi: 10.1111/j.1365-2559.1995.tb00647.x. [DOI] [PubMed] [Google Scholar]
  15. Morphopoulos G., Pearson M., Ryder W. D., Howell A., Harris M. Tumour angiogenesis as a prognostic marker in infiltrating lobular carcinoma of the breast. J Pathol. 1996 Sep;180(1):44–49. doi: 10.1002/(SICI)1096-9896(199609)180:1<44::AID-PATH648>3.0.CO;2-C. [DOI] [PubMed] [Google Scholar]
  16. Mountain C. F. Lung cancer staging classification. Clin Chest Med. 1993 Mar;14(1):43–53. [PubMed] [Google Scholar]
  17. O'Rourke M. A., Feussner J. R., Feigl P., Laszlo J. Age trends of lung cancer stage at diagnosis. Implications for lung cancer screening in the elderly. JAMA. 1987 Aug 21;258(7):921–926. [PubMed] [Google Scholar]
  18. Pendleton N., Jefferson M. F., Dixon G. R., Myskow M. W., Horan M. A. Correlates of tumor size, gender, cell type, and metastasis of resected non-small cell lung cancer and age. J Gerontol A Biol Sci Med Sci. 1996 Jan;51(1):B50–B53. doi: 10.1093/gerona/51a.1.b50. [DOI] [PubMed] [Google Scholar]
  19. Révész L., Siracka E., Siracky J., Delides G., Pavlaki K. Variation of vascular density within and between tumors of the uterine cervix and its predictive value for radiotherapy. Int J Radiat Oncol Biol Phys. 1989 May;16(5):1161–1163. doi: 10.1016/0360-3016(89)90274-5. [DOI] [PubMed] [Google Scholar]
  20. Siracká E., Révész L., Kovác R., Siracký J. Vascular density in carcinoma of the uterine cervix and its predictive value for radiotherapy. Int J Cancer. 1988 Jun 15;41(6):819–822. doi: 10.1002/ijc.2910410607. [DOI] [PubMed] [Google Scholar]
  21. Tahan S. R., Stein A. L. Angiogenesis in invasive squamous cell carcinoma of the lip: tumor vascularity is not an indicator of metastatic risk. J Cutan Pathol. 1995 Jun;22(3):236–240. doi: 10.1111/j.1600-0560.1995.tb00744.x. [DOI] [PubMed] [Google Scholar]
  22. Teeter S. M., Holmes F. F., McFarlane M. J. Lung carcinoma in the elderly population. Influence of histology on the inverse relationship of stage to age. Cancer. 1987 Sep 15;60(6):1331–1336. doi: 10.1002/1097-0142(19870915)60:6<1331::aid-cncr2820600628>3.0.co;2-x. [DOI] [PubMed] [Google Scholar]
  23. Van Hoef M. E., Knox W. F., Dhesi S. S., Howell A., Schor A. M. Assessment of tumour vascularity as a prognostic factor in lymph node negative invasive breast cancer. Eur J Cancer. 1993;29A(8):1141–1145. doi: 10.1016/s0959-8049(05)80304-1. [DOI] [PubMed] [Google Scholar]
  24. Weidner N. Tumor angiogenesis: review of current applications in tumor prognostication. Semin Diagn Pathol. 1993 Nov;10(4):302–313. [PubMed] [Google Scholar]
  25. Williams J. K., Carlson G. W., Cohen C., Derose P. B., Hunter S., Jurkiewicz M. J. Tumor angiogenesis as a prognostic factor in oral cavity tumors. Am J Surg. 1994 Nov;168(5):373–380. doi: 10.1016/s0002-9610(05)80079-0. [DOI] [PubMed] [Google Scholar]
  26. Yamazaki K., Abe S., Takekawa H., Sukoh N., Watanabe N., Ogura S., Nakajima I., Isobe H., Inoue K., Kawakami Y. Tumor angiogenesis in human lung adenocarcinoma. Cancer. 1994 Oct 15;74(8):2245–2250. doi: 10.1002/1097-0142(19941015)74:8<2245::aid-cncr2820740807>3.0.co;2-x. [DOI] [PubMed] [Google Scholar]
  27. Yuan A., Yang P. C., Yu C. J., Lee Y. C., Yao Y. T., Chen C. L., Lee L. N., Kuo S. H., Luh K. T. Tumor angiogenesis correlates with histologic type and metastasis in non-small-cell lung cancer. Am J Respir Crit Care Med. 1995 Dec;152(6 Pt 1):2157–2162. doi: 10.1164/ajrccm.152.6.8520790. [DOI] [PubMed] [Google Scholar]
  28. Yuhas J. M., Pazmino N. H., Proctor J. O., Toya R. E. A direct relationship between immune competence and the subcutaneous growth rate of a malignant murine lung tumor. Cancer Res. 1974 Apr;34(4):722–728. [PubMed] [Google Scholar]
  29. Zätterström U. K., Brun E., Willén R., Kjellén E., Wennerberg J. Tumor angiogenesis and prognosis in squamous cell carcinoma of the head and neck. Head Neck. 1995 Jul-Aug;17(4):312–318. doi: 10.1002/hed.2880170407. [DOI] [PubMed] [Google Scholar]
  30. de Jong J. S., van Diest P. J., Baak J. P. Heterogeneity and reproducibility of microvessel counts in breast cancer. Lab Invest. 1995 Dec;73(6):922–926. [PubMed] [Google Scholar]

Articles from British Journal of Cancer are provided here courtesy of Cancer Research UK

RESOURCES